{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1186/S12859-020-03929-0",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/dpgsea",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Command-line agent",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3336"
        },
        {
          "@id": "edam:topic_3308"
        },
        {
          "@id": "edam:topic_0154"
        }
      ],
      "sc:citation": [
        "pubmed:33435872",
        {
          "@id": "https://doi.org/10.1186/S12859-020-03929-0"
        },
        "pmcid:PMC7805197"
      ],
      "sc:description": "Drug perturbation gene set enrichment analysis (dpGSEA) can detect phenotypically relevant drug targets through a unique transcriptomic enrichment that emphasizes biological directionality of drug-derived gene sets.",
      "sc:featureList": [
        {
          "@id": "edam:operation_2436"
        },
        {
          "@id": "edam:operation_3223"
        },
        {
          "@id": "edam:operation_3938"
        }
      ],
      "sc:name": "dpGSEA",
      "sc:url": "https://github.com/sxf296/drug_targeting"
    }
  ]
}